You are here

  • Home
  • Archive
  • Volume 9, Issue 9
  • Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer

 

Online download statistics by month:

Online download statistics by month: September 2021 to March 2024

AbstractFullPdf
Sep 202111191122473
Oct 202138238177
Nov 202120320360
Dec 202114314473
Jan 202210010882
Feb 2022818844
Mar 2022110123120
Apr 2022959940
May 20229910559
Jun 2022939637
Jul 2022869439
Aug 202212512648
Sep 2022109115112
Oct 20229910342
Nov 202215015044
Dec 2022494917
Jan 202332833271
Feb 202310511647
Mar 2023808236
Apr 2023707026
May 2023727326
Jun 2023494929
Jul 2023515228
Aug 2023404123
Sep 2023636426
Oct 2023718331
Nov 202333333424
Dec 2023565640
Jan 2024656633
Feb 2024575737
Mar 2024818138
Total456446621882